Gili Regev-Yochay to Pneumococcal Vaccines
This is a "connection" page, showing publications Gili Regev-Yochay has written about Pneumococcal Vaccines.
Connection Strength
2.047
-
Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR). PLoS One. 2018; 13(11):e0206927.
Score: 0.490
-
Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel. Hum Vaccin Immunother. 2018; 14(10):2527-2532.
Score: 0.484
-
Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009-June 20151. Emerg Infect Dis. 2018 07; 24(7):1275-1284.
Score: 0.478
-
The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel. Vaccine. 2017 04 25; 35(18):2449-2456.
Score: 0.437
-
[THE EFFECT OF PNEUMOCOCCAL CONJUGATE VACCINE ON PNEUMOCOCCAL CARRIAGE AND INVASIVE DISEASE]. Harefuah. 2019 May; 158(5):316-320.
Score: 0.127
-
Hospital-onset adult invasive pneumococcal disease in Israel: Sicker patients, different pathogens. Int J Infect Dis. 2019 Aug; 85:195-202.
Score: 0.032